Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006
Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009
Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001
Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Airway acidification and exhaled nitric oxide in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003
Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005
Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002
Effects on exhaled nitric oxide levels and lung function of ultrasonically nebulized hypertonic solution in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003
Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003
Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
A 2-year follow-up of exhaled nitric oxide (FeNO) and pulmonary function tests in young patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Source: Eur Respir J 2001; 17: 1201-1207 Year: 2001
Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010